Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,532.00    -2.00 (-0.08%)
Bid:
2,537.00
Ask:
2,538.00
Spread: 1.00 (0.039%)
Market Cap: £25.53b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Interim Management Statement

27 Jul 2012 07:00

RNS Number : 6426I
3i Group PLC
27 July 2012
Β 

ο»Ώ

Β 

Β 

3i Group plc - Interim Management Statement

Β 

Β 

27 July 2012

Β 

3i Group plc ("3i"), an international investor in private equity, infrastructure and debt management, today issues its Interim Management Statement in accordance with FSA Disclosure and Transparency Rule 4.3. This statement relates to the three month period from 1 April 2012 to 30 June 2012 (the "period").

Β 

Simon Borrows, 3i's Chief Executive said:

"We are making good progress in implementing the strategic changes announced at the end of June to refocus our investment capabilities and reduce the Group's cost base."

Β 

Realisations

Β 

Realisations in the period were Β£119 million (2011: Β£337 million), generating net realised profits over 31 March 2012 value of Β£56 million (2011: Β£8 million) and a money multiple of 1.6x on a cash-to-cash basis. The most significant disposal related to EUSA Pharma, a legacy Venture Capital asset, which generated proceeds of Β£72 million and a profit of Β£42 million over 31 March 2012 value.

Β 

Realisation proceeds by business line were as follows:

Β 

Realisations Β£m

Β 

3 months ended

3 months ended

Β 

30 June

30 June

Β 

2012

2011

Private Equity

47

332

Infrastructure

-

-

Debt Management

-

-

Non-core activities

72

5

Total

119

337

Β 

The realisations in the period do not include proceeds in respect of the announced disposals of Hilite's SCR division (Private Equity, Germany) or the Group's holding in LNI (Infrastructure, Europe), which together are expected to generate further realisation proceeds of c.Β£70 million.

Β 

Investments

Β 

Cash investment from the Group's balance sheet was Β£65 million in the period.This primarily relates to the completion of the acquisition of GEKA (Private Equity,

Germany) announced in February, which is the last new investment in Eurofund V.

Β 

Investments during the period by business line were as follows:

Β 

Investment Β£m

Β 

3 months ended

3 months ended

Β 

30 June

30 June

Β 

2012

2011

Private Equity

49

161

Infrastructure

5

33

Debt Management1

11

-

Non-core activities

-

-

Total cash investment

65

194

Non cash investment2

6

39

Total gross investment

71

233

Β 

1

Debt Management investment reflects net cash investment in the quarter into the Credit Opportunities fund.

2

Non-cash investment includes capitalised interest and other of Β£21million (2011: Β£39million) offset by unsettled trades on the Credit Opportunities fund of Β£(15)million (2011: Β£nil).

Β 

Investment in the period does not include the Β£28 million investment in Blue Interactive (Private Equity, Brazil), which was announced in December 2011 and completed in July 2012.

Β 

Balance sheet

Β 

Gross debt as at 30 June 2012 was reduced to Β£1,254 million (31 March 2012: Β£1,623 million), following the Β£223 million repayment of the remaining balance of the June 2012 Floating Rate Note, and early repayment of €150 million of a €300 million bond, which is due to mature in May 2013. The early partial repayment of the May 2013 bond means full year interest costs have been accelerated into this quarter. The benefit in reduced costs will be seen next financial year.

Β 

Net debt increased to Β£490 million (31 March 2012: Β£464 million), as net divestment was offset by operating and interest costs. Consequently, gearing also increased to 19% (31 March 2012: 18%).

Β 

Liquidity was Β£1.3 billion (31 March 2012: Β£1.7 billion), comprising Β£764 million cash and cash deposits and Β£491 million undrawn committed facilities.

Β 

Portfolio

Β 

The unaudited valuations as at 30 June 2012 of our Top 10 assets are shown in the table below and reflect 30 June 2012 exchange rates. These comprise 43% of the total portfolio.

Β 

Top 10 Investments by value at 30 June 2012

Β 

Investment

Valuation

Valuation

Valuation

March 2012

June 2012

Geography

Basis

Β£m

Β£m

3i Infrastructure plc

UK

Quoted

375

364

Peer Holdings BV (Action)

Benelux

Earnings

143

137

Eco US Holding Inc (HILITE)

Germany

Earnings

115

128

Mayborn Group

UK

Earnings

105

113

Foster + Partners

UK

Earnings

112

112

Mold-Masters Luxembourg Acquisition S.A.R.L.

Canada

Earnings

115

111

ACR Capital Holdings Pte Ltd

Singapore

Industry metric

118

110

Element Materials Technology

Benelux

Earnings

90

97

Quintiles Transnational Corporation

US

Earnings

86

91

Scandferries Holding GmbH (Scandlines)

Germany

DCF/Earnings

89

86

Β 

The earnings used to value the Private Equity portfolio grew by 1% in aggregate and included the use of forecast accounts for 16% of companies (31 March 2012: 8%). Companies valued using forecast earnings accounted for 9% of the Private Equity portfolio value at 30 June 2012.

Β 

Earnings growth was largely offset by a reduction of 1% in multiples, resulting in broadly flat unrealised profits in the period to 30 June 2012. No new provisions were made in the period.

Β 

Returns

Β 

Unaudited NAV as at 30 June 2012 was Β£2.75 per share (31 March 2012: Β£2.79).

Β 

Along with the realised and unrealised profits noted above, the calculation of NAV also includes provision of Β£15 million for implementation costs relating to the strategic review of the business announced on 29 June 2012, a non-cash negative movement of Β£26 million relating to foreign exchange as the Euro and Rupee both continue to weaken against Sterling and a non-cash negative movement of Β£14 million relating to IAS 19 losses on the Group's pension fund due to corporate bond rates falling in the period.

Β 

Debt Management

Β 

On the 31 May 2012, the Debt Management team announced an agreement to acquire CLO fund management contracts from Invesco, which is subject to consents. The acquisition would add c.€2.0 billion of AUM and additional fee income to the Group.Β 

Β 

AGM and Investor meeting

Β 

On 29 June 2012, the Company held its Annual General Meeting and an Investor meeting. At the AGM, a final dividend of 5.4p was declared, giving rise to a cash payment of Β£50 million in July 2012. At the Investor meeting, 3i's new Chief Executive, Simon Borrows, set out 3i's future strategy as it relates to its investment strategy, asset management, operating costs, balance sheet and shareholder returns. The presentation is available at 3iGroup.com.

Β 

Ends

Β 

Β 

For further information, please contact:

Β 

Julia WilsonGroup Finance Director

Tel 020 7975 3285

Kathryn van der KroftPR Director, 3i Group plc

Tel: 020 7975 3021

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSRFMRTMBJTBRT
Date   Source Headline
30th Apr 20184:07 pmRNSDirector/PDMR Shareholding
4th Apr 201810:11 amRNSPortfolio Update
29th Mar 20182:02 pmRNSTotal Voting Rights
29th Mar 20181:59 pmRNSDirector/PDMR Shareholding
9th Mar 20188:30 amRNSAction refinancing and Capital Markets seminar
28th Feb 20183:44 pmRNSTotal Voting Rights
28th Feb 20183:44 pmRNSDirector/PDMR Shareholding
1st Feb 20183:51 pmRNSDirector/PDMR Shareholding
1st Feb 20187:00 amRNSFY2018 Q3 performance update
31st Jan 20184:17 pmRNSTotal Voting Rights
31st Jan 20184:16 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:15 pmRNSPortfolio Update
19th Dec 20173:18 pmRNSTotal Voting Rights
19th Dec 20173:15 pmRNSDirector/PDMR Shareholding
12th Dec 20173:05 pmRNSBlock listing Interim Review
6th Dec 201711:13 amRNSDirector/PDMR Shareholding
5th Dec 201712:00 pmRNSDirector/PDMR Shareholding
4th Dec 201710:32 amRNSDirector Declaration
30th Nov 20173:29 pmRNSTotal Voting Rights
30th Nov 20173:28 pmRNSDirector/PDMR Shareholding
16th Nov 201712:19 pmRNSDoc re. Half Yearly Report 2017
16th Nov 20177:00 amRNS3i Group Half-year results to 30 September 2017
31st Oct 20173:54 pmRNSDirector/PDMR Shareholding
31st Oct 20173:53 pmRNSTotal Voting Rights
3rd Oct 201712:37 pmRNSPortfolio Update
29th Sep 20173:51 pmRNSTotal Voting Rights
29th Sep 20173:50 pmRNSDirector/PDMR Shareholding
18th Sep 20178:30 amRNSPrivate Equity Capital Markets Seminar
31st Aug 20173:48 pmRNSTotal Voting Rights
31st Aug 20173:46 pmRNSDirector/PDMR Shareholding
31st Jul 20174:41 pmRNSTotal Voting Rights
31st Jul 20174:36 pmRNSDirector/PDMR Shareholding
28th Jul 20174:12 pmRNSDirector/PDMR Shareholding
26th Jul 20173:14 pmRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSQ1 Performance update
6th Jul 20173:24 pmRNSPortfolio Update
30th Jun 20174:28 pmRNSDirector/PDMR Shareholding
30th Jun 20173:18 pmRNSTotal Voting Rights
30th Jun 20173:17 pmRNSDirector/PDMR Shareholding
29th Jun 20172:54 pmRNSResult of AGM
29th Jun 20172:35 pmRNSDoc re. AGM Resolutions
29th Jun 20172:25 pmRNSDirector/PDMR Shareholding
19th Jun 20174:19 pmRNSDTR 6.3.5
13th Jun 201711:26 amRNSDirector/PDMR Shareholding
12th Jun 20174:48 pmRNSBlock listing Interim Review
2nd Jun 201711:16 amRNSDirector/PDMR Shareholding
31st May 20174:25 pmRNSTotal Voting Rights
31st May 20174:21 pmRNSDirector/PDMR Shareholding
31st May 201710:12 amRNSDoc re. 2017 Annual Report and Accounts
30th May 20178:30 amRNSPrivate Equity Capital Markets Seminar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.